ARS Pharmaceuticals Income Statement (2020-2026) | SPRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)				0.00B	0.00B	0.00B		0.00B	0.00B				0.00B	0.00B	0.09B	0.01B	0.02B	0.03B	0.03B	0.02B
Operating items
Research & Development (Quarter)	0.02B	0.02B	-0.03B	0.01B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.01B	0.01B	-0.02B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.04B	0.04B	0.05B	0.07B	0.06B	0.07B
Other Operating Expenses (Quarter)						-0.00B		0.01B						0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Operating Expenses (Quarter)	0.02B	0.02B	-0.04B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.02B	0.02B	0.04B	0.05B	0.06B	0.09B	0.07B	0.08B
Operating Income (Quarter)	-0.02B	-0.02B	0.05B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	0.05B	-0.04B	-0.05B	-0.05B	-0.04B	-0.06B
EBIT (Quarter)	-0.02B	-0.02B	0.05B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	0.05B	-0.04B	-0.05B	-0.05B	-0.04B	-0.06B
Non-operating items
Interest & Investment Income (Quarter)		-0.00B	0.00B				0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B
Other Non Operating Income (Quarter)				-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.01B	0.00B
Net income details
EBT (Quarter)	-0.15B	-0.04B	0.05B	-0.01B	-0.01B	-0.02B	-0.02B	-39.41B	-38.20B	-15.46B	-0.01B	-0.09B	-0.07B	-0.16B	0.05B	-0.04B	-0.22B	-0.11B	-0.04B	-0.10B
Profit After Tax (Quarter)	-0.02B	-0.02B	0.05B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	0.05B	-0.03B	-0.05B	-0.05B	-0.04B	-0.06B
Income from Continuing Operations (Quarter)	-0.15B	-0.04B	0.05B	-0.01B	-0.01B	-0.02B	-0.02B	-39.41B	-38.20B	-15.46B	-0.01B	-0.09B	-0.07B	-0.16B	0.05B	-0.04B	-0.22B	-0.11B	-0.04B	-0.10B
Consolidated Net Income (Quarter)	-0.15B	-0.04B	0.05B	-0.01B	-0.01B	-0.02B	-0.02B	-39.41B	-38.20B	-15.46B	-0.01B	-0.09B	-0.07B	-0.16B	0.05B	-0.04B	-0.22B	-0.11B	-0.04B	-0.10B
Income towards Parent Company (Quarter)	-0.15B	-0.04B	0.05B	-0.01B	-0.01B	-0.02B	-0.02B	-39.41B	-38.20B	-15.46B	-0.01B	-0.09B	-0.07B	-0.16B	0.05B	-0.04B	-0.22B	-0.11B	-0.04B	-0.10B
Net Income towards Common Stockholders (Quarter)	-0.15B	-0.04B	0.05B	-0.01B	-0.01B	-0.02B	-0.02B	-39.41B	-38.20B	-15.46B	-0.01B	-0.09B	-0.07B	-0.16B	0.05B	-0.04B	-0.22B	-0.11B	-0.04B	-0.10B
Additional items
EPS (Basic) (Quarter)	-4.18	-1.27	1.35	-0.33	-0.39	-0.43	-0.38	-418.21	-402.49	-161.76	-0.11	-0.94	-0.70	-1.60	0.49	-0.38	-2.26	-1.14	-0.44	-0.97
EPS (Diluted) (Quarter)		-1.27	1.63	-0.38	-0.44	-0.43	-0.38	-418.21	-402.49	-161.76	-0.11	-0.94	-0.70	-1.60	0.46	-0.38	-2.26	-1.14	-0.44	-0.97
Shares Outstanding (Quarter)	0.03B	0.04B	0.03B	0.04B	0.04B	0.04B	0.04B	0.09B	0.09B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B
Shares Outstanding (Diluted) (Quarter)		0.04B	0.03B	0.03B	0.03B	0.04B	0.04B	0.09B	0.09B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B
EBITDA (Quarter)	-0.02B	-0.02B	0.05B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	0.05B	-0.04B	-0.05B	-0.05B	-0.04B	-0.06B
Interest Expenses (Quarter)	0.12B	0.02B	-0.00B	0.00B	0.01B	0.01B	0.00B	39.39B	38.18B	15.44B		0.08B	0.05B	0.13B	-0.00B	0.00B	0.17B	0.06B	0.00B	0.04B

Research Tools

Developers

ARS Pharmaceuticals Income Statement (2020-2026) | SPRY

Research Tools

Developers

ARS Pharmaceuticals Income Statement (2020-2026) | SPRY

Create an account

Sign In

Reset Password